KaydedilenlerDerginizi ekleyin

Dergiler / Marmara Medical Journal / 2026 / Volume: 39 Issue: 2

The effect of epigenetic regulation on apoptosis and ferroptosis in A549 and MRC-5 cell lines

Venhar Gurbuz Can(KARABUK UNIVERSITY)0000-0002-9777-5173
Tansu Kuşat(Karabuk University)0000-0001-7237-1562
Sayfa
—
Yayın Tarihi
2026-05-21
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our results indicate that the expression levels of the epigenetic regulators DNMT1 and EZH2 are elevated in lung cancer cells, which is associated with reduced apoptotic signaling, as indicated by decreased caspase-3 expression, and suppression of ferroptosis through increased GPX4 expression.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Lung cancer represents the second most prevalent form of malignancy on a global scale and is associated with the highest mortality rate of all cancers.
📊
Temel Bulgular & Veri:Materials and Methods: The MRC-5 and A549 cell lines were cultivated under the optimal conditions for their growth.
💡
Sonuç & Katkı:Conclusion: Our results indicate that the expression levels of the epigenetic regulators DNMT1 and EZH2 are elevated in lung cancer cells, which is associated with reduced apoptotic signaling, as indicated by decreased caspase-3 expression, and suppression of ferroptosis through increased GPX4 expression.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Lung cancer · Apoptosis · Ferroptosis

Abstract

Objective: Lung cancer represents the second most prevalent form of malignancy on a global scale and is associated with the highest mortality rate of all cancers. The objective of this study is to investigate the gene expression profiles of various cell death pathways in healthy lung cells and lung cancer cells. Furthermore, the study seeks to establish how epigenetically associated genes regulate these pathways. Materials and Methods: The MRC-5 and A549 cell lines were cultivated under the optimal conditions for their growth. The isolation of RNA, the subsequent synthesis of cDNA, and the analysis of quantitative real-time PCR were performed in order to measure the expression levels of EZH2, DNMT1, caspase-3, and GPX4 genes in the cells. Results: The findings of this study indicate an upregulation of the epigenetic regulators DNMT1 and EZH2, as well as the ferroptosis inhibitor GPX4, in A549 lung cancer cells. Concurrently, a decrease in caspase-3 gene expression was observed. Conclusion: Our results indicate that the expression levels of the epigenetic regulators DNMT1 and EZH2 are elevated in lung cancer cells, which is associated with reduced apoptotic signaling, as indicated by decreased caspase-3 expression, and suppression of ferroptosis through increased GPX4 expression.

🔖

Bu Makaleye Atıf Yap

Can, V. G., Kuşat, T. (2026). The effect of epigenetic regulation on apoptosis and ferroptosis in A549 and MRC-5 cell lines. Marmara Medical Journal, Volume: 39 Issue: 2. https://doi.org/10.5472/marumj.1951321

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (33)

  1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209- 49. doi: 10.3322/caac.21660.
  2. Orabi MAA, Alqahtani OS, Alyami BA, et al. Human lung cancer (A549) Cell Line cytotoxicity and anti-leishmania major activity of carissa macrocarpa leaves: A study supported by UPLC-ESI-MS/MS metabolites profiling and molecular docking. Pharmaceuticals (Basel). 2022;15:1561. doi: 10.3390/ ph15121561.
  3. Fangjun L, Zhijia Y. Tumor suppressive roles of eugenol in human lung cancer cells. Thoracic Cancer 2018;9:25-9. doi: https://doi.org/10.1111/1759-7714.12508.
  4. Garcia-de-Alba C. Repurposing A549 adenocarcinoma cells: New options for drug discovery. Am J Respir Cell Mol Biol 2021;64:405-6. doi: 10.1165/rcmb.2021-0048ED.
  5. Martines-Arano H, Arano-Martinez JA, Mosso-Pani MA, et al. Fractional electrodamage in A549 human lung cancer cells. Fractal Fract 2025;9:34.
  6. Yap JMG, Ueda T, Kanemitsu Y, et al. Human lung fibroblasts exhibit induced inflammation memory via increased IL6 gene expression and release. Front Immunol 2022;13:2022. doi: 10.3389/fimmu.2022.921728.
  7. Hamilton JP. Epigenetics: principles and practice. Dig Dis 2011;29:130-5. doi: 10.1159/000323874.
  8. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148- 59. doi: 10.1056/NEJMra072067.
  9. Selaru FM, David S, Meltzer SJ, Hamilton JP. Epigenetic events in gastrointestinal cancer. Am J Gastroenterol 2009;104:1910- 2. doi: 10.1038/ajg.2008.145.
  10. Liu G, Pei F, Yang F, et al. Role of autophagy and apoptosis in non-small-cell lung cancer. Int J Mol Sci 2017;18:367. doi: 10.3390/ijms18020367.
  11. Gokbayrak Atay I, Gezer A, Kasap E. The importance of apoptosis in cancer development and treatment. oncology. Turk J Oncol 2021;36:381-88.
  12. Abdel-Fattah MM, Mohamed WR, Hassanein EHM, Arab HA, Arafa E-sA. Role of NF-κB/ICAM-1, JAK/STAT-3, and apoptosis signaling in the anticancer effect of tangeretin against urethane-induced lung cancer in BALB/c mice. Life Sci 2023;325:121749. doi: 10.1016/j.lfs.2023.121749.
  13. Xing N, Du Q, Guo S, et al. Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy. Cell Death Discov 2023;9:110. doi: doi: 10.1038/ s41420-023-01407-z.
  14. Wu P, Zhang X, Duan D, Zhao L. Organelle-specific mechanisms in crosstalk between apoptosis and ferroptosis. Oxid Med Cell Longev 2023;2023:3400147. doi: 10.1155/2023/3400147.
  15. Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 2015;520(7545):57-62. doi: 10.1038/nature14344.
  16. Kim J-W, Min DW, Kim D, et al. GPX4 overexpressed nonsmall cell lung cancer cells are sensitive to RSL3-induced ferroptosis. Sci Rep 2023;13:8872. doi: 10.1038/s41598-023- 35978-9
  17. Zhang C, Wang C, Yang Z, et al. Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance. Trans Lung Cancer Res 2022;11:786-801.
  18. Liu K, Jin M, Xiao L, Liu H, Wei S. Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer. Cancer Manag Res 2018;10:2997-3005. doi: 10.1186/s12967-024-05112-y
  19. Li Z, Lu W, Yin F, Zeng P, Li H, Huang A. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma. J Trans Med 2024;22:340. doi: 10.1186/s12967.024.05112-y.
  20. Ran Q, Van Remmen H, Gu M, et al. Embryonic fibroblasts from Gpx4+/ – mice: a novel model for studying the role of membrane peroxidation in biological processes. Free Radic Biol Med 2003;35:1101-9. doi: 10.1016/s0891-5849(03)00466-0.
  21. Okouoyo S, Herzer K, Ucur E, et al. Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo. Int J Cancer 2004;108:580-7. doi: 10.1002/ ijc.11585.
  22. Volm M, Mattern J, Koomägi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res 1999;19:1669-71.
  23. Dimou A, Dincman T, Evanno E, Gemmill RM, Roche J, Drabkin HA. Epigenetics during EMT in lung cancer: EZH2 as a potential therapeutic target. Cancer Treat Res Commun 2017;12:40-8. doi: https://doi.org/10.1016/j.ctarc.2017.06.003.
  24. Liu Y, Yang Q. The roles of EZH2 in cancer and its inhibitors. Med Oncol 2023;40:167. doi: 10.1007/s12032-023-02025-6.
  25. Hou P, Liu D, Dong J, Xing M. The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells. Cell Cycle 2012;11:286-95. doi: 10.4161/ cc.11.2.18707.
  26. Wu J, Tang Q, Yang L, Chen Y, Zheng F, Hann SS. Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells. Sci Rep 2017;7:509. doi: 10.1038/s41598-017-00626-6.
  27. Christofides A, Karantanos T, Bardhan K, Boussiotis VA. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2. Oncotarget 2016;7:85624-40. doi: 10.18632/oncotarget.12928.
  28. Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res 2018;6:10. doi: 10.1186/s40364-018-0122-2.
  29. Wang X, Zhao H, Lv L, Bao L, Wang X, Han S. Prognostic significance of EZH2 Expression in non-small cell lung cancer: A Meta-analysis. Sci Rep 2016;6:19239. doi: 10.1038/ srep19239.
  30. Fan J, Lin H, Luo J, Chen L. 4‑Methoxydalbergione inhibits the tumorigenesis and metastasis of lung cancer through promoting ferroptosis via the DNMT1/system Xc‑/ GPX4 pathway. Mol Med Rep 2025;31:19. doi: 10.3892/ mmr.2024.13384.
  31. Dai Y, Chen J, Duan Q. Epigenetic mechanism of EZH2- mediated histone methylation modification in regulating ferroptosis of alveolar epithelial cells in sepsis-induced acute lung injury. Drug Dev Res 2024;85:e22263. doi: 10.1002/ ddr.22263.
  32. Zeng H, Li T, He X, et al. Oxidative stress mediates the apoptosis and epigenetic modification of the Bcl-2 promoter via DNMT1 in a cigarette smoke-induced emphysema model. Respir Res 2020;21:229. doi: 10.1186/s12931-020-01495-w.
  33. Ren X, Bai X, Zhang X, et al. quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells. Mol Cell Proteomics 2015;14:316-28. doi: 10.1074/mcp.M114.041905.